FDA approves Aurobindo’s Geodon generic

SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Geodon (ziprasidone HCl) capsules, the company announced Wednesday. The drug is indicated to treat schizophrenia. 

 

Aurobindo’s generic will be available in 20-, 40-, 60- and 80-mg dosage strengths. The drug has an estimated market size of $117 million for the 12 months ended November 2016, according to QuintilesIMS.